A population PK model for citalopram and its major metabolite, N-desmethyl citalopram, in rats

Nieves Velez de Mendizabal, Kimberley Jackson, Brian Eastwood, Steven Swanson, David M. Bender, Stephen Lowe, Robert Bies

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

A population PK model was developed in order to simultaneously describe citalopram and its major metabolite, n-desmethyl citalopram, plasma concentrations in two different strain of rats after intravenous (IV) and oral (PO) administration of citalopram. Citalopram was administered to Sprague–Dawley (SD) rats at doses: 0.3, 1, 3, and 10 mg/kg IV and 10 mg/kg PO. The compound was dosed orally to Wistar rats at doses: 0.3, 1, 3, 10, 30 and 60 mg/kg. Plasma samples were collected for citalopram and metabolite. Pharmacokinetic analyses were conducted using NONMEM 7.2. Values below the quantification limit (BLQ

Original languageEnglish (US)
Pages (from-to)721-733
Number of pages13
JournalJournal of Pharmacokinetics and Pharmacodynamics
Volume42
Issue number6
DOIs
StatePublished - Sep 22 2015

Fingerprint

Citalopram
Population
Oral Administration
Wistar Rats
Pharmacokinetics

Keywords

  • Citalopram
  • Metabolite
  • N-desmethyl citalopram
  • NONMEM

ASJC Scopus subject areas

  • Pharmacology

Cite this

A population PK model for citalopram and its major metabolite, N-desmethyl citalopram, in rats. / Velez de Mendizabal, Nieves; Jackson, Kimberley; Eastwood, Brian; Swanson, Steven; Bender, David M.; Lowe, Stephen; Bies, Robert.

In: Journal of Pharmacokinetics and Pharmacodynamics, Vol. 42, No. 6, 22.09.2015, p. 721-733.

Research output: Contribution to journalArticle

Velez de Mendizabal, Nieves ; Jackson, Kimberley ; Eastwood, Brian ; Swanson, Steven ; Bender, David M. ; Lowe, Stephen ; Bies, Robert. / A population PK model for citalopram and its major metabolite, N-desmethyl citalopram, in rats. In: Journal of Pharmacokinetics and Pharmacodynamics. 2015 ; Vol. 42, No. 6. pp. 721-733.
@article{047e3321038148b0a4584effa94fe556,
title = "A population PK model for citalopram and its major metabolite, N-desmethyl citalopram, in rats",
abstract = "A population PK model was developed in order to simultaneously describe citalopram and its major metabolite, n-desmethyl citalopram, plasma concentrations in two different strain of rats after intravenous (IV) and oral (PO) administration of citalopram. Citalopram was administered to Sprague–Dawley (SD) rats at doses: 0.3, 1, 3, and 10 mg/kg IV and 10 mg/kg PO. The compound was dosed orally to Wistar rats at doses: 0.3, 1, 3, 10, 30 and 60 mg/kg. Plasma samples were collected for citalopram and metabolite. Pharmacokinetic analyses were conducted using NONMEM 7.2. Values below the quantification limit (BLQ",
keywords = "Citalopram, Metabolite, N-desmethyl citalopram, NONMEM",
author = "{Velez de Mendizabal}, Nieves and Kimberley Jackson and Brian Eastwood and Steven Swanson and Bender, {David M.} and Stephen Lowe and Robert Bies",
year = "2015",
month = "9",
day = "22",
doi = "10.1007/s10928-015-9448-7",
language = "English (US)",
volume = "42",
pages = "721--733",
journal = "Journal of Pharmacokinetics and Pharmacodynamics",
issn = "1567-567X",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - A population PK model for citalopram and its major metabolite, N-desmethyl citalopram, in rats

AU - Velez de Mendizabal, Nieves

AU - Jackson, Kimberley

AU - Eastwood, Brian

AU - Swanson, Steven

AU - Bender, David M.

AU - Lowe, Stephen

AU - Bies, Robert

PY - 2015/9/22

Y1 - 2015/9/22

N2 - A population PK model was developed in order to simultaneously describe citalopram and its major metabolite, n-desmethyl citalopram, plasma concentrations in two different strain of rats after intravenous (IV) and oral (PO) administration of citalopram. Citalopram was administered to Sprague–Dawley (SD) rats at doses: 0.3, 1, 3, and 10 mg/kg IV and 10 mg/kg PO. The compound was dosed orally to Wistar rats at doses: 0.3, 1, 3, 10, 30 and 60 mg/kg. Plasma samples were collected for citalopram and metabolite. Pharmacokinetic analyses were conducted using NONMEM 7.2. Values below the quantification limit (BLQ

AB - A population PK model was developed in order to simultaneously describe citalopram and its major metabolite, n-desmethyl citalopram, plasma concentrations in two different strain of rats after intravenous (IV) and oral (PO) administration of citalopram. Citalopram was administered to Sprague–Dawley (SD) rats at doses: 0.3, 1, 3, and 10 mg/kg IV and 10 mg/kg PO. The compound was dosed orally to Wistar rats at doses: 0.3, 1, 3, 10, 30 and 60 mg/kg. Plasma samples were collected for citalopram and metabolite. Pharmacokinetic analyses were conducted using NONMEM 7.2. Values below the quantification limit (BLQ

KW - Citalopram

KW - Metabolite

KW - N-desmethyl citalopram

KW - NONMEM

UR - http://www.scopus.com/inward/record.url?scp=84945481632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945481632&partnerID=8YFLogxK

U2 - 10.1007/s10928-015-9448-7

DO - 10.1007/s10928-015-9448-7

M3 - Article

C2 - 26395999

AN - SCOPUS:84945481632

VL - 42

SP - 721

EP - 733

JO - Journal of Pharmacokinetics and Pharmacodynamics

JF - Journal of Pharmacokinetics and Pharmacodynamics

SN - 1567-567X

IS - 6

ER -